Dr. Clove: Do not eat Lianhua Qingwen to prevent the new crown!
The reason is this, the epidemic in Shanghai is serious, and Lianhua Qingwen has been widely distributed to Shanghai residents .
In this regard, Dr. Lilac believes that it is really unnecessary to distribute Lianhua Qingwen to healthy citizens.
And analyze it from many aspects:
1. From the perspective of virus prevention: Lianhua Clearing the plague is useless.
In terms of physical blockage, vaccines, or medication to prevent infection, even Hua Qingwen cannot prevent new crowns virus effect.
2. From the three dimensions of official to clinical, and drug development, there is currently no effective evidence to support “Lianhua Qingwen can prevent new crowns”.
It also added that the widely spread online statement that “the World Health Organization recommends Lianhua Qingwen” is incorrect.
Clinicians also do not recommend the use of Lianhua Qingwen as a new crown preventive drug. “Whether it is from the instructions of the drug or the mechanism of Lianhua Qingwen’s medicine, Lianhua Qingwen cannot prevent the new crown. What’s more, Lianhua Qingwen is an oral drug, and there is a problem of uncertainty about the oral course of treatment. That is to say Any drug has time to metabolize in the human body. After taking it once, the drug will be metabolized. It is difficult to prevent disease by oral administration.”
“I haven’t seen it yet. Until Lianhua Qingwen conducted randomized controlled trials in this regard, there was no conclusive evidence that it could effectively prevent new coronavirus infection.”
Finally, from a From the point of view of the verification mechanism of the drug, even Hua Qingwen did not meet the process of proving that it could be prevented.
3. Don’t take any medicine when you are not sick, even Hua Qingwen is the same
Although the above materials have already stated that Lianhua Qingwen is useless to prevent the new crown, but in the face of an anxiety-provoking epidemic, many people may have the mentality of “prefer to have it”: If there are drugs, it is better to take them than not to take them, right?
In this regard, Dr. Lilac said bluntly: Don’t take medicine indiscriminately when you are not sick, even Hua Qingwen. Because eating it is not only useless to prevent the new crown, but also has risks.
From the ingredient list, Lianhua Qingwen is composed of 13 traditional Chinese medicines: Forsythia, honeysuckle, roasted ephedra, fried bitter almond, gypsum, Banlangen, Mianma Guanzhong, Houttuynia cordata, patchouli, rhubarb, rhodiola, menthol, licorice. Lianhua Qingwen is banned in New Zealand due to its controlled drug ingredients, and Sweden, the United States, Italy, and Australia have also banned Lianhua Qingwen from entering the country.
The study published in “Frontiers in Pharmacology” pointed out that Lianhua Qingwen contains at least 61 compounds with extremely complex components. There are some side effects, common adverse reactions are gastrointestinal adverse reactions such as nausea, vomiting, abdominal pain, diarrhea, abdominal distension, nausea, as well as rash, itching, dry mouth, dizziness, etc.
In the instructions of Lianhua Qingwen, it is marked with caution in patients with hypertension and heart disease; people with severe chronic diseases such as liver disease, diabetes, kidney disease, children, pregnant women, Lactating women, the elderly and the infirm also need to take it under the guidance of a physician.
“A drug that can’t prevent the new crown, is distributed in large quantities to healthy people who are not infected. .
It is even more unreasonable if it really takes up the transportation capacity of other materials for the transportation and distribution of these drugs, as some reports say. .
We don’t think it should be.”
According to the data, Dr. Lilac is a brand of Lilac Garden which specializes in health consultation and popular science information services for the general public at the C-end. Since its establishment in July 2014, Dr. Clove currently has four major functions: popular science content, online consultation, prescription advice, and health services. The sudden outbreak of COVID-19 in 2020 has made Dr. Clove quickly become a hot product. By swiping the screen in the WeChat Moments, its functions such as epidemic dynamics, refuting rumors, and online consultation have largely helped solve many pain points in epidemic prevention. Dr. Clove has already It is a big V and a unicorn in the Internet medical industry.
Wang Sicong previously questioned: The China Securities Regulatory Commission should strictly investigate Yiling Pharmaceutical
p>
It is worth noting that before Dr. Lilac took action, Wang Sicong, the “Chairman of Beijing Pusi Capital and Director of Wanda Group” with 40 million fans, also questioned.
On the afternoon of April 14, Wang Sicong forwarded a message about Hua Qingwen on Weibo, and commented that “the China Securities Regulatory Commission should strictly investigate Yiling Pharmaceutical” . Wang Sicong reposted a Weibo video titled “Editorial Department Before Bedtime”, titled “WHO “recommended” Lianhua Qingwen, who told you?” The owner of the account said that he “has questioned Lianhua many times.” The efficacy and marketing model of Qingwen”.
Wang Sicong’s reposts and comments attracted widespread attention. About an hour after reposting, Wang Sicong re-edited the above-mentioned Weibo and deleted the “CSRC should strictly investigate Yiling Pharmaceutical.” ”, etc., but still retain the content forwarded above.
The next day, on April 15th, Yiling Pharmaceutical opened sharply lower and then went down. It fell to the limit for the first time after more than half an hour. After about two hours of “struggling”, the market finally fell to the limit, and the market value evaporated by 6.7 billion.
Yi Ling previously responded: We have obvious inhibitory effect on the new coronavirus
But WHO did not recommend Lianhua Qingwen
April On the afternoon of the 16th, according to China Entrepreneur Magazine, Yiling Pharmaceutical responded positively to Wang Sicong’s question. “The relevant person in charge of Yiling Pharmaceutical” stated to “Chinese Entrepreneur”: “The company has never stated on any occasion that ‘WHO recommends Lianhua Qingwen'”. “The above-mentioned person in charge explained that the WHO recognized the efficacy of traditional Chinese medicine including Lianhua Qingwen on the new coronary pneumonia.”
And on April 15th , When the secretary of the board of Yiling Pharmaceutical was answering questions from investors at Interactive Yi, some investors said: “ Yiling is really popular. Recently, there have been many people on the Internet questioning the efficacy of Lianhua Qingwen’s treatment and prevention of new crowns. I hope the company can stand up and speak out.”
In response, Yiling Pharmaceutical responded: “We have also paid attention to the relevant public opinion on the Internet. We believe in “clearing the clear”, and will continue to track the development of the situation, and will protect our legitimate rights and interests through legal means when necessary.
Lianhua Qingwen is an innovative patented traditional Chinese medicine developed under the guidance of collateral disease theory. In 2020, the “Research and Application of Chinese Medicine Lianhua Qingwen in the Treatment of Novel Coronavirus Pneumonia” won the first prize of Hebei Province Science and Technology Progress. Lianhua Qingwen has been listed in the National Health Commission and the National Health Commission. The “New Coronary Virus Pneumonia Diagnosis and Treatment Program” jointly issued by the State Administration of Traditional Chinese Medicine (trial version 4/5/6/7/8/9) and the new crown pneumonia diagnosis and treatment programs of more than 20 provinces and cities are the “anti-epidemic” of traditional Chinese medicine. One of the representative medicines of “Three Sides and Three Medicines”. Lianhua Qingwen is a collection of three well-known traditional Chinese medicines that have been fighting against epidemics for two thousand years, and adds medicines that aromatize dampness, protect the spleen and stomach, improve immunity and strengthen Qi, which has broad-spectrum antiviral properties. It has multiple functions such as antibacterial and anti-inflammatory, effective prevention and treatment of lung infection, and improvement of body immunity. Lianhua Qingwen was developed during the SARS epidemic prevention and control in 2003, and played an important role in the prevention and control of influenza A in 2009 , has made significant contributions to the prevention and control of the new crown pneumonia epidemic since 2020, and has been registered and applied in Hong Kong, Macau and nearly 30 countries in China. Many authoritative scientific research institutions in China focus on Lianhua Qingwen’s anti-new crown Pneumonia has carried out a series of basic and clinical research, forming a “cell-animal-prophylactic drug-clinical treatment” evidence chain for the prevention and treatment of new coronary pneumonia. Mickron and others have obvious inhibitory effects.35 experimental and clinical research papers have been published (15 published abroad). Efficacy and safety research of the “Prospective Open-Label Controlled Trial” real-world research paper was published in the international journal Evidence-Based Complementary and Alternative Medicine. The results of the study confirmed: The positive rate of nucleic acid detection in the Lianhua Qingwen intervention group was 0.27% The positive rate of Lianhua Qingwen was significantly lower than the control group’s positive rate of 1.14% (with statistical significance). The preventive application of Lianhua Qingwen in the close contact group can reduce the positive infection rate of new coronary pneumonia by 76%, and the safety is good.
On March 24, 2022, in order to further guide the scientific To standardize the prevention and treatment of new coronary pneumonia by traditional Chinese medicine, the Hebei Provincial Administration of Traditional Chinese Medicine has researched and formulated the traditional Chinese medicine diagnosis and treatment plan of the national “New Coronavirus Pneumonia Diagnosis and Treatment Plan (Trial Version 9)” and summed up the experience of traditional Chinese medicine prevention and control in Hebei Province. “Hebei Province Novel Coronavirus Pneumonia Traditional Chinese Medicine Prevention and Control Program (Trial Version 6)”, Lianhua Qingwen Capsules (granules) were recommended 8 times, and were used for prevention and medical observation period, asymptomatic infection, mild, general Type and severe treatment. Among them, the usage and dosage of Lianhua Qingwen capsules (granules) for the prevention of new coronary pneumonia are: adults 2 to 4 capsules (half bag to 1 bag) each time, 3 times a day; children under 10 years old, Lianhua Qingwen granules 1/3 to 1/2 bag each time, 3 times a day; children over 10 years old, the dosage is the same as adults, for 7 to 10 days.
At present, the company is making every effort to do a good job in scientific research, quality and quantity production, ensuring market supply, for the Contribute to epidemic prevention and control. I call on everyone to fight the epidemic together, overcome the difficulties together, and rationally identify the false remarks on Yiling Pharmaceutical and Lianhua Qingwen on the Internet. ”
“responsive layout”img class=”content_title sizes” =”(min-width: 320px) 320px, 100vw” src=”https://mmbiz.qpic.cn/mmbiz_png/7KcgpBE2JbrTjNBQRnibw3lQVtbZeYPHuBnLtNYGCnyIow457HZ6ZNdIw9mmxZK1sKLB04rjWI2Cz8vAfImZ0gQ/640″img -galleryid=”” data-ratio=”0.5375″ data-type=”jpeg” data-w=”1280″ layout=”responsive” sizes=”(min-width: 320px) 320px, 100vw” src=”300,640″ srcrc=”https://mmbiz.qpic. cn/mmbiz_jpg/7KcgpBE2JbraHabK3F7jp6eiakM5PiaqS9tx8icZAibDBuia8ghgzicw7q2U0BiclAPLiaKiabicQX7EakLlicibpKBLprfHfA/640?wx_fmt=jpeg”>
Very critical moment! Unicorns soared on the first day of listing, and Li Zekai’s net worth exceeded 30 billion!